ProMab: ProMab Presents Promising Results in Humanized CD19 CAR-T Cells Trial

RICHMOND, Calif.-(BUSINESS WIRE)-ProMab Biotechnology, Inc., a leading developer of CAR-T/NK cell technology for global life sciences, announced today it has successfully completed an investigator initiated trail (IIT) for CAR-T cell therapy. The study was conducted at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology by Prof. Hu Yu and Prof. Mei Heng [...]The post ProMab Presents Promising Results in Humanized CD19 CAR-T Cells Trial appeared first on Drug Genius.